Longeveron Granted Canadian Patent for Method of Using Stem Cells to Treat Non-Ischemic Dilated Cardiomyopathy and Aging-related Frailty in Patients with Inflammaging

Thepatent relates to methods of administering therapeutically effective amounts of isolated allogeneic mesenchymal stem cells (MSCs) to patients ...
Fierce Pharma

Italian nonprofit lands FDA approval for 1st gene therapy to treat rare genetic disease

The FDA has issued its stamp of approval to a new, cell-based option to treat Wiskott-Aldrich syndrome (WAS), marking the ...
Medical Dialogues

FDA Approves First Gene Therapy Treatment for Wiskott-Aldrich Syndrome

The U.S. Food and Drug Administration has approved Waskyra (etuvetidigene autotemcel), the first cell-based gene therapy for ...

FDA Approves First Gene Therapy Treatment For Rare Immune Disorder Wiskott-Aldrich Syndrome

The U.S. Food and Drug Administration has approved Waskyra (etuvetidigene autotemcel), the first cell-based gene therapy for the treatment of a rare, genetic immune disorder ...
pharmaphorum

Why pharma’s future may run through your local blood centre

Despite their readiness, blood centres remain an underutilised lever in pharma’s innovation model. As industry players seek ...
The Manila Times

Fate Therapeutics Presents Updated Phase 1 Clinical Data of FT819 Off-the-shelf CAR T-cell Product Candidate for Systemic Lupus Erythematosus and Preclinical Advances in Next ...

FT819 continues to demonstrate meaningful decrease in disease and favorable safety profile with twelve systemic lupus erythematosus (SLE) patients now treated; first systemic sclerosis (SSc) patient t ...

Longeveron New MRI Biomarker Data Linking Neuroinflammation to Clinical Outcomes in Patients with Mild Alzheimer’s Disease Presented at the Clinical Trials on Alzheimer’s ...

Results obtained in the Phase 2 placebo-controlled CLEAR-MIND clinical trial showed that treatment with stem cell therapy laromestrocel was ...

Sana Biotechnology, Inc. (SANA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Citi Annual Global Healthcare Conference 2025 December 2, 2025 2:30 PM ESTCompany ParticipantsSteven Harr - President, ...
Everyday Health on MSN

Can you get a pancreas transplant for type 1 diabetes?

Pancreas transplants are rare, but they may help some people with type 1 diabetes produce insulin on their own. Learn the ...
MyChesCo on MSN

FDA’s week of breakthroughs: New gene therapy, new antibiotics, new rules

The Food and Drug Administration rolled out a rapid-fire series of moves this month that could reshape how Americans manage ...

Patients can safely receive stem cell transplants from mismatched and unrelated donors, study shows

For years, the search for a stem cell donor has felt like a quest for a rare key—one that fits a lock with eight intricate tumblers, each representing a genetic marker. For many patients with blood ...

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

A new study shows that giving the chemotherapy drug cyclophosphamide after allogeneic hematopoietic cell transplantation, a curative treatment for common types of blood cancer, can make the procedure ...